| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.4M | +19.8% |
| Cost of Revenue | $13.7M | -5.7% |
| Gross Profit | $2.7M | +436.1% |
| R&D Expense | $39.7M | +45.9% |
| SG&A Expense | $31.6M | +8.5% |
| Operating Income | -$68.6M | -20.0% |
| Interest Expense | $18.7M | +11.9% |
| Income Tax | $0 | — |
| Net Income | $142.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.8M | +7.0% |
| Short-term Investments | $108.2M | +12.2% |
| Inventory | $7.3M | +15.7% |
| Current Assets | $161.2M | +11.6% |
| Total Assets | $177.7M | -10.7% |
| Current Liabilities | $31.5M | +71.1% |
| Long-term Debt | $56.4M | -5.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.3M | -18.2% |
| Investing Cash Flow | $26.9M | +118.1% |
| Financing Cash Flow | $41.8M | -81.0% |
| +147.0% |
| EPS (Basic) | $0.30 | +141.7% |
| EPS (Diluted) | -$0.11 | +84.7% |
| Total Liabilities |
| $142.6M |
| -62.9% |
| Stockholders' Equity | -$2.6M | +98.6% |